EP3720429A4 - COMPOSITIONS BASED ON CROMOGLICIC ACID AND RELATED PROCESSES - Google Patents

COMPOSITIONS BASED ON CROMOGLICIC ACID AND RELATED PROCESSES Download PDF

Info

Publication number
EP3720429A4
EP3720429A4 EP17934303.3A EP17934303A EP3720429A4 EP 3720429 A4 EP3720429 A4 EP 3720429A4 EP 17934303 A EP17934303 A EP 17934303A EP 3720429 A4 EP3720429 A4 EP 3720429A4
Authority
EP
European Patent Office
Prior art keywords
methods
cromolyn
compositions
cromolyn compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17934303.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3720429A1 (en
Inventor
David R. Elmaleh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/830,980 external-priority patent/US10525005B2/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP3720429A1 publication Critical patent/EP3720429A1/en
Publication of EP3720429A4 publication Critical patent/EP3720429A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
EP17934303.3A 2017-12-04 2017-12-28 COMPOSITIONS BASED ON CROMOGLICIC ACID AND RELATED PROCESSES Withdrawn EP3720429A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/830,980 US10525005B2 (en) 2013-05-23 2017-12-04 Cromolyn compositions and methods thereof
PCT/US2017/064526 WO2019112552A1 (en) 2017-12-04 2017-12-28 Cromolyn compositions and methods thereof

Publications (2)

Publication Number Publication Date
EP3720429A1 EP3720429A1 (en) 2020-10-14
EP3720429A4 true EP3720429A4 (en) 2021-09-15

Family

ID=66751145

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17934303.3A Withdrawn EP3720429A4 (en) 2017-12-04 2017-12-28 COMPOSITIONS BASED ON CROMOGLICIC ACID AND RELATED PROCESSES

Country Status (8)

Country Link
EP (1) EP3720429A4 (ja)
JP (1) JP2021505658A (ja)
KR (1) KR20200096567A (ja)
CN (1) CN111629719A (ja)
AU (1) AU2017442079A1 (ja)
CA (1) CA3084593A1 (ja)
MX (1) MX2020005615A (ja)
WO (1) WO2019112552A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466863A1 (en) * 2001-11-29 2003-06-05 Emisphere Technologies, Inc. Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
EP3563849A3 (en) * 2012-10-25 2020-02-12 The General Hospital Corporation Combination therapies for the treatment of alzheimer's disease and related disorders
EP2999337A4 (en) * 2013-05-23 2017-03-15 Aztherapies, Inc Methods for delivering cromolyn
EP3060205A4 (en) * 2013-10-22 2017-06-28 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10265296B2 (en) * 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
AU2016359674A1 (en) * 2015-11-23 2018-06-14 The General Hospital Corporation Compositions and methods for treating ischemic stroke

Also Published As

Publication number Publication date
AU2017442079A1 (en) 2020-06-25
KR20200096567A (ko) 2020-08-12
MX2020005615A (es) 2020-11-25
JP2021505658A (ja) 2021-02-18
CA3084593A1 (en) 2019-06-13
EP3720429A1 (en) 2020-10-14
CN111629719A (zh) 2020-09-04
WO2019112552A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
EP3589373A4 (en) COMPOSITIONS AND PROCEDURES FOR IMMUNOTHERAPY
EP3600325A4 (en) UNIQUE COMPOSITIONS AND PROCESSES
EP3600271A4 (en) PROCEDURES AND COMPOSITIONS FOR THE IMPROVEMENT OF HEALTH
IL271275A (en) Preparations containing coronas and their uses
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
EP3503879A4 (en) COMPOSITION AND METHOD FOR IT
EP3704227A4 (en) COMPOSITION AND PROCESS
EP3635100A4 (en) COMPOSITIONS AND METHOD OF EXPRESSION OF OTOFERLIN
GB201807325D0 (en) Compositions and methods
GB202201859D0 (en) Novel methods and compositions
EP3436083A4 (en) NEW COMPOSITIONS AND METHODS
EP3442543A4 (en) COMPOSITIONS AND METHODS FOR NEUROGENESIS
EP3642219A4 (en) PEPTIDE COMPOSITIONS AND RELATED PROCEDURES
EP3704224A4 (en) NUTRITIONAL COMPOSITIONS AND RELATED PROCESSES
TWI799417B (zh) 生物製藥組成物及相關方法
EP3706558A4 (en) AQUACULTURE COMPOSITIONS AND PROCESSES
EP3709871A4 (en) COMPOSITIONS AND METHODS TO IMPROVE VISUAL FUNCTION
EP3691629A4 (en) NUTRIENT SPORE FORMULATIONS AND THEIR USES
EP3316871A4 (en) TALKED COMPOSITION AND USES THEREOF
EP3612230A4 (en) PALBOCICLIB COMPOSITIONS AND RELATED METHODS
ZA202004533B (en) Skin-brightening compositions and methods
EP3349748A4 (en) COMPOSITION AND METHOD THEREFOR
EP3635324A4 (en) REVERSE FREEZING COMPOSITIONS AND USE OF THEM
EP3570874A4 (en) ZWITTERIONIC-INSULIN POLYMER COMPOSITIONS AND RELATED METHODS
EP3558268A4 (en) DROXIDOPA COMPOSITIONS AND PROCEDURES

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200605

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40039234

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20210813

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20210809BHEP

Ipc: A61K 47/26 20060101ALI20210809BHEP

Ipc: A61K 9/14 20060101ALI20210809BHEP

Ipc: A61K 31/352 20060101ALI20210809BHEP

Ipc: A61K 31/192 20060101AFI20210809BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220311